FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry and pharmacy. Disclosed is application 2-(4-carboxybenzylidene)-3,4-dihydronaphthalen-1(2H)-one as an agent possessing cytotoxic activity. Invention can be promising in medical practice for treating cancer diseases and obtaining agents having cytotoxic action, which can be used as active components of antineoplastic drugs, including against leukemia.
EFFECT: compound suppressed metabolic activity of pig embryo kidney cell lines carrying oncovirus A and C (SPEV), rat glioma (C6), human cervix uteri cancer tumor (HeLa).
1 cl, 3 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 4-(2,4-DIMETHOXYPHENYL)-2-(2-HYDROXYPHENYL)-5,6-DIHYDRO-4N-BENZO[H]CHROMENE-3-CARBOXYLIC ACID, HAVING CYTOTOXIC ACTIVITY | 2019 |
|
RU2707972C1 |
| ARILMETHYLENE BISPIRAN-2-ONE-BASED COMPLEX COMPOUNDS OF COPPER(II) EXHIBITING CYTOTOXIC ACTIVITY TO HELA CELL LINE | 2020 |
|
RU2753853C1 |
| PHARMACEUTICAL COMPOSITION FOR ONCOLOGICAL DISEASES | 2011 |
|
RU2463053C1 |
| METHYL-3-ARYL-3A-NITRO-4-(TRIFLUOROMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCHROMENO[3,4-C]PYRROLE-1-CARBOXYLATES, HAVING CYTOTOXIC ACTIVITY ON CELL LINE HUMAN CERVICAL CARCINOMA HELA, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2818191C1 |
| NEW AMINE DERIVATIVES OF FUSIDIC ACID EXHIBITING ANTITUMOUR ACTIVITY | 2019 |
|
RU2735665C1 |
| AGENT PREVENTING MAMMAL NORMAL CELL TRANSFORMATION IN MALIGNANT CELLS | 2010 |
|
RU2429839C1 |
| METHOD OF OBTAINING 4,5-DIARYLAZOLES | 2022 |
|
RU2799312C2 |
| AGENT HAVING SELECTIVE ACTION ON TUMOR CELLS, ACTIVATING APOPTOSIS THEREOF AND PREVENTING FORMATION OF RESISTANCE THEREOF | 2018 |
|
RU2694547C1 |
| N-GLYCOSIDES OF INDOLO[2,3-a]PYRROLO[3,4-c]CARBAZOLES HAVING ANTITUMOUR ACTIVITY | 2014 |
|
RU2548045C1 |
| CELL LINE OF RAT GLIOMA C6-DDA RESISTANT TO CYTOTOXIC ACTION OF N-ACYL DOPAMINE, FOR STUDYING MECHANISMS OF BIOACTIVE LIPIDS ACTION | 2017 |
|
RU2694868C2 |
